Search - tctmd.com

Displaying 601 - 620 of 696

Sort: Relevancy | Date

News Industry News

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

November 08, 2011

News Conference News

Mock Jury Votes on DAPT Duration: 12 Months Remains Best Option for Most Patients

November 08, 2011

News Conference News

Low Event Rates with EES Sustained at 2 Years

November 08, 2011

News Conference News

ZES, EES Noninferior to PES

November 07, 2011

News Industry News

Three-Year Clinical Outcomes from Use of GenousTM Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy

November 07, 2011

News Conference News

SAT-TAVI: Data Support TAVR Without Dual Antiplatelet Therapy

November 07, 2011

News Industry News

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

November 07, 2011

News Conference News

GHOST: Accurate Medical History May Predict DAPT Adherence in PCI for STEMI

November 06, 2011

News Conference News

Early Discontinuation of DAPT May Increase Risk of Stent Thrombosis

November 06, 2011

News Industry News

Data from REMEDEE Trial Featuring OrbusNeich's ComboTM Dual Therapy Stent to Be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011

November 01, 2011

News Industry News

Data Published in Circulation Journal Show OrbusNeich's GenousTM Stent Is Safe and Effective in Elderly Patients

October 25, 2011

News Daily News

Early Study Shows Pelvic Stenting for Erectile Dysfunction Safe, Feasible

October 21, 2011

News Daily News

First DES for Above-the-Knee Vascular Disease on the Horizon

L.A. McKeown

October 18, 2011

News Daily News

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

October 17, 2011

News Daily News

Six Months Sufficient for Dual Antiplatelet Therapy

Jason Kahn

October 17, 2011

News Daily News

Antiplatelet Therapy Plus SSRI Spurs Bleeding After MI

Yael L. Maxwell

September 26, 2011

News Daily News

Clopidogrel Reactions Treatable Without Stopping Antiplatelet Therapy

September 21, 2011

News Daily News

Model Tries to Simplify Choice Between Drug-Eluting, Bare-Metal Stents

L.A. McKeown

September 16, 2011

News Daily News

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

September 14, 2011

News Daily News

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

September 12, 2011

Advertisement

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

Mock Jury Votes on DAPT Duration: 12 Months Remains Best Option for Most Patients

Low Event Rates with EES Sustained at 2 Years

ZES, EES Noninferior to PES

Three-Year Clinical Outcomes from Use of GenousTM Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy

SAT-TAVI: Data Support TAVR Without Dual Antiplatelet Therapy

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

GHOST: Accurate Medical History May Predict DAPT Adherence in PCI for STEMI

Early Discontinuation of DAPT May Increase Risk of Stent Thrombosis

Data from REMEDEE Trial Featuring OrbusNeich's ComboTM Dual Therapy Stent to Be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011

Data Published in Circulation Journal Show OrbusNeich's GenousTM Stent Is Safe and Effective in Elderly Patients

Early Study Shows Pelvic Stenting for Erectile Dysfunction Safe, Feasible

First DES for Above-the-Knee Vascular Disease on the Horizon

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

Six Months Sufficient for Dual Antiplatelet Therapy

Antiplatelet Therapy Plus SSRI Spurs Bleeding After MI

Clopidogrel Reactions Treatable Without Stopping Antiplatelet Therapy

Model Tries to Simplify Choice Between Drug-Eluting, Bare-Metal Stents

Meta-analysis: Everolimus-Eluting Stents Reduce Thrombosis vs. Other DES

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content